You have 9 free searches left this month | for more free features.

City

Beijing (1)

Condition

Lymphoma (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Peking University (1)

Collaborator

Intervention

plerixafor,g-csf (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

plerixafor,g-csf

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lymphoma Trial in Beijing (Plerixafor,G-CSF)

Not yet recruiting

Lymphoma

Plerixafor,G-CSF

Beijing, Beijing, China

Peking University Cancer Hospital & Institute

Aug 19, 2022